Title
Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia
"Insulin Fast Dissolving Film for Intranasal Delivery Via Olfactory Region, a Promising Approach for the Treatment of Anosmia in COVID 19 Patients: Design, In-vitro Characterization and Clinical Evaluation."
Phase
Phase 2Lead Sponsor
Deraya UniversityStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Anosmia [, ]Intervention/Treatment
Insulin film ...Study Participants
40The study aimed to investigate the efficacy of insulin in a new dosage form ( fast dissolving film) in treatment of anosmia in patients post infested with Covid-19. The study implication based in two methods evaluations
Threshold test
identification test.
This study was designed to improve smell disorders after corona infection that is very anxious for all patients.
Inclusion criteria were loss of smell, post covid-19 infection, age from 18 to 70 years and accept sharing and follow up.
The application of dosage form by ENT specialist at otorhinolaryngology clinic at Minia University hospital. Dose was 100iu of insulin 3 times weekly for 4 weeks. The new dosage form with insulin was compared with a placebo to ensure statistical improvement.
The tests were performed in each visit. Primary outcome was the improvement of smell sensors in those patients
Insulin suspension vials
Fast dissolving film
Formulated bioadhesive fast dissolving film contains 100IU of insulin
Formulated bioadhesive fast dissolving film contains no drug
Inclusion Criteria: anosmia post covid-19 infection Exclusion Criteria: nasal polyps or fractions or syrgery in nose from 6 months or less